McKesson Corporation
NYQ: MCKLive Quote
📈 ZcoreAI Score
Our AI model analyzes McKesson Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get MCK Z-Score →About McKesson Corporation
Healthcare
Medical Distribution
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
📊 Fundamental Analysis
McKesson Corporation demonstrates a profit margin of 1.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 11.4% revenue growth, which is above average for the Healthcare sector.
At a current price of $865.60, MCK currently sits at the 63rd percentile of its 52-week range (Range: $637.00 - $999.00).
💰 Valuation Insight
MCK is valued broadly in line with the sector at a PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
⚠️
Revenue Growth
Moderate
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$106.84B
Trailing P/E
25.00
Forward P/E
19.44
Beta (5Y)
0.42
52W High
$999.00
52W Low
$637.00
Avg Volume
781K
Day High
Day Low